227 related articles for article (PubMed ID: 19635471)
21. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system.
Ehlers MD
Nat Neurosci; 2003 Mar; 6(3):231-42. PubMed ID: 12577062
[TBL] [Abstract][Full Text] [Related]
22. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W
Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837
[TBL] [Abstract][Full Text] [Related]
23. Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
Srivastava A; Das B; Yao AY; Yan R
J Alzheimers Dis; 2020; 78(4):1345-1361. PubMed ID: 33325389
[TBL] [Abstract][Full Text] [Related]
24. Shank3 is localized in axons and presynaptic specializations of developing hippocampal neurons and involved in the modulation of NMDA receptor levels at axon terminals.
Halbedl S; Schoen M; Feiler MS; Boeckers TM; Schmeisser MJ
J Neurochem; 2016 Apr; 137(1):26-32. PubMed ID: 26725465
[TBL] [Abstract][Full Text] [Related]
25. Organization of postsynaptic density proteins and glutamate receptors in axodendritic and dendrodendritic synapses of the rat olfactory bulb.
Sassoé-Pognetto M; Utvik JK; Camoletto P; Watanabe M; Stephenson FA; Bredt DS; Ottersen OP
J Comp Neurol; 2003 Aug; 463(3):237-48. PubMed ID: 12820158
[TBL] [Abstract][Full Text] [Related]
26. POSH regulates assembly of the NMDAR/PSD-95/Shank complex and synaptic function.
Yao M; Meng M; Yang X; Wang S; Zhang H; Zhang F; Shi L; Zhang Y; Zhang X; Xu Z
Cell Rep; 2022 Apr; 39(1):110642. PubMed ID: 35385725
[TBL] [Abstract][Full Text] [Related]
27. Regulation of A-kinase anchoring protein 79/150-cAMP-dependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin.
Gomez LL; Alam S; Smith KE; Horne E; Dell'Acqua ML
J Neurosci; 2002 Aug; 22(16):7027-44. PubMed ID: 12177200
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.
Colledge M; Snyder EM; Crozier RA; Soderling JA; Jin Y; Langeberg LK; Lu H; Bear MF; Scott JD
Neuron; 2003 Oct; 40(3):595-607. PubMed ID: 14642282
[TBL] [Abstract][Full Text] [Related]
29. Decreased levels of NMDA but not AMPA receptors in the lipid-raft fraction of 3xTg-AD model of Alzheimer's disease: Relation to Arc/Arg3.1 protein expression.
Morin JP; Díaz-Cintra S; Bermúdez-Rattoni F; Delint-Ramírez I
Neurochem Int; 2016 Nov; 100():159-163. PubMed ID: 27650435
[TBL] [Abstract][Full Text] [Related]
30. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism.
Bangash MA; Park JM; Melnikova T; Wang D; Jeon SK; Lee D; Syeda S; Kim J; Kouser M; Schwartz J; Cui Y; Zhao X; Speed HE; Kee SE; Tu JC; Hu JH; Petralia RS; Linden DJ; Powell CM; Savonenko A; Xiao B; Worley PF
Cell; 2011 May; 145(5):758-72. PubMed ID: 21565394
[TBL] [Abstract][Full Text] [Related]
31. Zinc Stabilizes Shank3 at the Postsynaptic Density of Hippocampal Synapses.
Tao-Cheng JH; Toy D; Winters CA; Reese TS; Dosemeci A
PLoS One; 2016; 11(5):e0153979. PubMed ID: 27144302
[TBL] [Abstract][Full Text] [Related]
32. Eppendorf 2003 prize-winning essay. Ubiquitin and the deconstruction of synapses.
Ehlers MD
Science; 2003 Oct; 302(5646):800-1. PubMed ID: 14593160
[No Abstract] [Full Text] [Related]
33. Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
Deng Y; Wei J; Cheng J; Zhong P; Xiong Z; Liu A; Lin L; Chen S; Yan Z
J Alzheimers Dis; 2016 Jun; 53(4):1419-32. PubMed ID: 27372643
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a.
Sala C; Futai K; Yamamoto K; Worley PF; Hayashi Y; Sheng M
J Neurosci; 2003 Jul; 23(15):6327-37. PubMed ID: 12867517
[TBL] [Abstract][Full Text] [Related]
35. Ontogeny of postsynaptic density proteins at glutamatergic synapses.
Petralia RS; Sans N; Wang YX; Wenthold RJ
Mol Cell Neurosci; 2005 Jul; 29(3):436-52. PubMed ID: 15894489
[TBL] [Abstract][Full Text] [Related]
36. Postsynaptic density assembly is fundamentally different from presynaptic active zone assembly.
Bresler T; Shapira M; Boeckers T; Dresbach T; Futter M; Garner CC; Rosenblum K; Gundelfinger ED; Ziv NE
J Neurosci; 2004 Feb; 24(6):1507-20. PubMed ID: 14960624
[TBL] [Abstract][Full Text] [Related]
37. Quantification of postsynaptic density proteins: glutamate receptor subunits and scaffolding proteins.
Shinohara Y
Hippocampus; 2012 May; 22(5):942-53. PubMed ID: 21594948
[TBL] [Abstract][Full Text] [Related]
38. Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.
Atkin G; Moore S; Lu Y; Nelson RF; Tipper N; Rajpal G; Hunt J; Tennant W; Hell JW; Murphy GG; Paulson H
J Neurosci; 2015 Apr; 35(15):6165-78. PubMed ID: 25878288
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of postsynaptic density-95-interacting regulator of spine morphogenesis reduces glutamate-induced excitotoxicity by differentially regulating glutamate receptors in rat cortical neurons.
Luo P; Yang Y; Liu W; Rao W; Bian H; Li X; Chen T; Liu M; Zhao Y; Dai S; Yan X; Fei Z
FEBS J; 2013 Dec; 280(23):6114-27. PubMed ID: 24103031
[TBL] [Abstract][Full Text] [Related]
40. Long-term potentiation in isolated dendritic spines.
Corera AT; Doucet G; Fon EA
PLoS One; 2009 Jun; 4(6):e6021. PubMed ID: 19547754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
